Money20/20 Europe once again provided a valuable snapshot of where the fintech and payments industry is heading. While artificial intelligence remained a dominant theme, the broader conversati...
Ophthalmology 2024 Update
March 27, 2024
Private equity’s investments in ophthalmology are entering a new, more mature lifecycle phase. We expect continued transaction volume, though with a smaller average deal size. We also expect many platform recapitalizations once private equity groups and lenders become comfortable with the interest rate environment.
Written by
Eric Yetter
Managing Director, Healthcare Team Leader
Eric Yetter is an investment banker focused on healthcare provider services. Eric has completed a variety of healthcare transactions, many with private equity firms and PE-backed companies. His past clients include leading physician and dental groups, behavioral health companies, healthcare facilities, and institutional healthcare investors.
View Bio
Written by
Eric Yetter
Managing Director, Healthcare Team Leader
Related Insights
Let's connect
M&A guidance, backed by real experience
Whether you’re exploring a sale, raising capital, or simply want an outside perspective on where your business stands, our bankers are ready to listen. Reach out to start a confidential conversation with the FOCUS team.
